The reliability of 
The recent introduction of immunohistological methods for the detection of oestrogen receptors in paraffin wax sections provides a much needed facility for examination of routinely processed histological material. [1] [2] [3] Recently, we assessed the use of one of these methods in a study of 19 cases of mucinous breast carcinoma, a tumour known to be rich in oestrogen receptor content. We found the results consistent with those obtained by the standard dextran-coated charcoal biochemical assay in the cases examined by both methods. 4 The current study was aimed at assessing the same immunohistological method in a large series of breast carcinomas found to be oestrogen receptor negative by the biochemical assay.
Methods
The study included 60 consecutive cases of breast carcinoma with oestrogen receptor concentrations of less than 10 fmol/mg cytosol protein, as estimated by the dextran-coated charcoal biochemical assay.5 All tumours were removed surgically at Charing Cross Hospital between 1979-1982. The original haematoxylin and eosin stained sections were reviewed and a representative section of each case was selected. Sections 5 ,um thick were cut from the corresponding formalin fixed, paraffin wax embedded blocks of tumour tissue and used for the immunohistological study.
As previously described,4 the sections were dewaxed, hydrated through graded alcohols, and rinsed in TRIS buffer (pH 7 6). Endogenous peroxidase activity was blocked by using 0-50o hydrogen peroxide in methanol for 10 minutes. The method described by Shintaku and Said for the demonstration of oestrogen receptors in paraffin wax sections' was then applied. The sections were covered with DNAse I (Sigma D5025) solution in a moist chamber for two hours. The concentration of the DNAse solution was decided by titrating against a known oestrogen receptor positive control case, using doubling dilutions from 40 mg to 5 mg per ml of 0-01M magnesium sulphate in TRIS buffer. It is essential to do this for each batch of DNAse as the enzyme activity may vary considerably.6 In this study the enzyme activity was 2200 Kunitz units per mg solid, and a dilution of20 mg per ml (44 000 Kunitz units per ml) was found to be optimal.
The sections were then rinsed in TRIS buffered saline (TBS), covered for 30 minutes with normal goat serum, followed by overnight incubation in a moist chamber with several drops of ER-ICA monoclonal antibody (Abbott Laboratories England). After rinsing in TBS the sections were successively covered for two hours each with goat anti-rat immunoglobulin and rat peroxidase-anti-peroxidase complex. This was followed by rinsing in TBS, incubation in diaminobenzidine for 10 minutes, washing in tap water and light counterstaining with haematoxylin. A control slide from each case was treated similarly except for replacement of the specific antiserum with the negative control antibody supplied with the ER-ICA kit.
The staining results were assessed semiquantitatively according to the percentage of cells stained and the intensity of the staining, as previously described.4 A scale of 1-3 was used for each of these two components. For the percentage of stained cells, 1 referred to stain- [1979] [1980] [1981] [1982] . The two main differences between the two groups were a significantly much higher incidence of medullary carcinoma (p < 0 001) and a low incidence of invasive lobular carcinoma (p < 0 001) in the oestrogen receptor negative group. The immunohistological brown positive staining, when present, was restricted to the nuclei of neoplastic cells and some non-neo- ,n oestrogen ing degrees of positivity, while intraductal a, estimated carcinoma of the comedo type was mostly rst, to assess negative. he immunoIt is concluded that the immunohistological D routinely method used in this study for the demonstra-)r the deter-tion of oestrogen receptor in routinely procestr content of sed paraffin wax sections can be reliably used assess the for the determination of the oestrogen receptor the negative content of negative as well as positive tumours.
In particular, negative staining in this and in our previous study,4 was only seen in biochemically oestrogen receptor negative tumours. It seems, however, that a minority of biochemically oestrogen receptor negative tumours may show positive staining. The staining in most of these cases is weak, and for practical purposes these tumours may have to be considered negative, especially if the faint staining is localised to a small area. In small moderately stained tumours the results obtained with this method are probably more accurate than those obtained by biochemical assay, because of the possibility of sampling errors. The most critical step of the method is the determination of the suitable concentration of DNAse that can be used and this has to be decided by titration of each new batch of the enzyme. The method would be particularly valuable for the assessment of the oestrogen receptor content of the increasing numbers of small tumours likely to be encountered in clinical practice with the introduction of the National Breast Screening Programme. In many of these small tumours, or suspected tumours, no tissue will be available for biochemical assay and frozen section examination will be contraindicated. The whole lesion has to be examined thoroughly by paraffin wax sections, some of which can be used for assessment of oestrogen receptor content by this method, if and when it is needed. This study was supported by a grant from the Peel Medical Research Trust.
